Kinesio Taping With &Without Craniosacral Therapy in Pregnant Females With SIJ Dysfunction.

Not Applicable

Completed

• Conditions: Sacral Disorder

• Registration Number: NCT05811325
• Lead Sponsor: Riphah International University

Brief Summary

SIJ dysfunction adversely affects quality of life and causes functional impairment and disability. Although, K taping and craniosacral therapy were previously affective in treating SI joint dysfunction, the combined affects of these intervention have not been compared previously to K taping alone.

Detailed Description

This study is a randomized controlled trial and have 30 pregnant women suffering from SIJH dysfunction. There is 2 groups and both have received treatment for 6 weeks. The data on pain is collected through VAS and the data on disability is collected through Oswestry Disability Index, and data on quality of life will be collected using SF-36. Measurements will be taken at the beginning of the study and at the end of the 4th week, at the completion of the study. Data will be analyzed using SPSS.

Study Timeline

• Study Start: 2022-02-11
• Primary Completion: 2022-12-30
• Study Completion: 2023-01-30
• Status Verified: 2023-03
• Study First Submitted: 2023-03-31
• Study First Submitted QC: 2023-03-31
• Last Update Submitted: 2023-03-31
• Study First Posted: 2023-04-13
• Last Update Posted: 2023-04-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

• age between 18-35
• pregnant females in 3rd trimester
• pregnant females with SIJ dysfunction

Exclusion Criteria

• high risk pregnancy
• pregnant females with hypermobility syndrome
• previous pelvic history

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
VISUAL ANALOGUE SCALE	6 WEEKS	This scale is used to assess pain.
Oswestry Disability Index	4 weeks	it is used to measure disability.

Secondary Outcome Measures

Name	Time	Method
SF-36	4 weeks	Data on quality of life is measured by this scale.

Trial Locations

Locations (1)

Mayo Hopital; 🇵🇰 Lahore, Pakistan